Login / Signup

Cost-Effectiveness Analysis of Antimicrobial Prescribing in the Treatment of Clostridioides Difficile Infection in England.

Tom BromilowHayden HolmesLaura CooteSam WoodsJoshua Pink
Published in: PharmacoEconomics - open (2023)
First-line vancomycin and second-line vancomycin was the most cost-effective treatment sequence at the NICE threshold for treating CDI in England. The main limitation of this study was that the initial cure and recurrence rates of each intervention were applied constantly across each line of treatment and each round of recurrence.
Keyphrases
  • primary care
  • emergency department
  • randomized controlled trial
  • staphylococcus aureus
  • combination therapy
  • replacement therapy
  • clostridium difficile
  • free survival